Through Labcorp OnDemand, the panel will be available from 3 August 2026.
Comprehensive gene panel testing, one of the exciting new tools in cancer diagnostics, warrants greater scrutiny—as does a federal program aimed at speeding up the review process for proposed new ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of Marker ...
Demand for germline hereditary cancer genetic testing has increased because of reduced cost, gene discovery, expanding indications, and precision cancer therapies. The traditional model for germline ...
Ms. Charité Ricker, MS, CGC and Dr. Nadine Tung, MD, FASCO share updates from the new ASCO guideline on selection of germline genetic testing panels in patients with cancer. They discuss highlights on ...
Please provide your email address to receive an email when new articles are posted on . A kidney disease panel for 382 genes yielded a high success rate and was effective in identifying monogenic ...
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAstat-Dx Rise – a high-capacity version of the QIAstat-Dx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results